Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using retro-inverso peptides derived from interleukin-6

Methods of using retro-inverso peptides derived from interleukin-6

US Patent 7754688 · Granted Jul 13, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and kits for predicting infusion reaction risk and antibody-mediated los2025
Methods and kits for predicting infusion reaction risk and antibody-mediated los2024
Methods and kits for predicting infusion reaction risk and antibody-mediated los2023
Methods and kits for predicting infusion reaction risk and antibody-mediated los2023
Methods and kits for predicting infusion reaction risk and antibody-mediated los2020
Methods and kits for predicting infusion reaction risk and antibody-mediated los2018
Methods and kits for predicting infusion reaction risk and antibody-mediated los2016
Retro-inverso peptides derived from interleukin-62011
Method of using retro inverso peptides derived from leukemia inhibitory factor2010
Method of using retro inverso peptides derived from leukemia inhibitory factor2010
Retro-inverso peptides derived from interleukin-62006
Retro-inverso peptides derived from interleukin-62006